Advisors Preferred’s Allergan plc AGN Stock Holding History

Advisors Preferred’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-60	Closed	-$13K	–	285
2016 Q4	$13K	Buy	+60	New	+$12.4K	0.01%	172
2015 Q1	–	Hold	0	–	–	–	248

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Advisors Preferred's AGN Position: Q1 2017 in Review

Advisors Preferred sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 60 shares — an estimated $13K sold.

Advisors Preferred first reported a position in AGN in Q4 2016 and held it in 1 quarter. The position peaked at $13K in Q4 2016. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

Advisors Preferred reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
Advisors Preferred sold 60 Allergan plc shares in Q1 2017, an estimated $13K.
Advisors Preferred first reported a position in Allergan plc in Q4 2016 and held it in 1 quarter.
Advisors Preferred's Allergan plc position peaked at $13K in Q4 2016.
1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Advisors Preferred's 13F filing for Q1 2017, filed 3 May 2017.